Home
LEXEO Therapeutics

LEXEO Therapeutics Market Share Analysis for June 2026

Lexeo Therapeutics is a team focused on our people and our patients. We invite you to join our team to advance therapies for those in need.

Health > Biotechnology and Pharmaceuticals

Domainlexeotx.com

Year Founded2018

Employees51 - 200

Annual Revenue< $1M

LEXEO Therapeutics

LEXEO Therapeutics (including company regionals)

lexeotx.com

See more website traffic and engagement information

Total visits to LEXEO Therapeutics's top domains

Understand LEXEO Therapeutics market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

lexeotx.com11.3K

See more with Sales Intelligence

Avg. visit duration in LEXEO Therapeutics's top domains

Analyze LEXEO Therapeutics engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

lexeotx.com00:01:13

See more with Sales Intelligence

Avg. pageviews on LEXEO Therapeutics's top domains

See how LEXEO Therapeutics keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

lexeotx.com1.61

See more with Sales Intelligence

LEXEO Therapeutics top competitors by domain

Top similar sites in June 2026, ranked by their affinity

rocketpharma.comCompany NameRocket PharmaceuticalsEmployees201 - 500HQUnited States, New Jersey, CranburyAnnual revenue$25M - $50MTotal visits14.4KHealth > Biotechnology and Pharmaceuticals

Top technologies used by LEXEO Therapeutics

These are the website technologies, by industry, used by LEXEO Therapeutics top domains

Widget (4)

Twemoji

Mobile (3)

Meta Viewport

Content Management System (2)

WordPress

Email Services (2)

Microsoft Exchange Online

More Technologies

6

See all

News & Signals from LEXEO Therapeutics

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsLexeo Therapeutics, Inc. attended event 2026 RBC Capital Markets Global Healthcare Conference on May 19th '26.NEW YORK, May 19, 2026 (GLOBE NEWSWIRE) - Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, today announced that the Company will participate in a fireside chat at the 2026 RBC Capital Markets Global Healthcare Conference on Tuesday, May 19, 2026 at 2:35 p.m. ET in New York, NY.

NewsLexeo Therapeutics, Inc. hired Laura Sepp-Lorenzino on Apr 28th '26.Lexeo Therapeutics, Inc. appointed Dr. Laura Sepp-Lorenzino to its board of directors effective April 28, 2026.

NewsLexeo Therapeutics, Inc. attended event 29th American Society of Gene & Cell Therapy (ASGCT) Annual Meeting on May 11th '26.NEW YORK, April 27, 2026 (GLOBE NEWSWIRE) - Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering novel treatments for cardiovascular diseases, announced today that new data supporting its cardiac gene therapy programs and optimized AAV manufacturing approach will be presented at the 29th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) taking place May 11-15, 2026 in Boston, MA.